The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
Open Access
- 1 June 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (25), 16998-17005
- https://doi.org/10.1074/jbc.m109.007625
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) InhibitorsAntimicrobial Agents and Chemotherapy, 2009
- Combinations of Cyclophilin Inhibitor NIM811 with Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of ResistanceAntimicrobial Agents and Chemotherapy, 2008
- Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In VitroJournal of Virology, 2008
- The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virusHepatology, 2008
- Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In VitroJournal of Virology, 2007
- Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2007
- The control of viral infection by tripartite motif proteins and cyclophilin ARetrovirology, 2007
- NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha InterferonAntimicrobial Agents and Chemotherapy, 2006
- Diverse Effects of Cyclosporine on Hepatitis C Virus Strain ReplicationJournal of Virology, 2006
- Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811Biochemical and Biophysical Research Communications, 2006